Research Article

Analysis of Various Types of Glomerulonephritis with Crescents at a Single Center

Table 4

Univariate and multivariate analysis of factors affecting renal prognosis microscopic polyangiitis and immunoglobulin A nephropathy.

Univariate analysisMultivariate analysis
HR95% CI valueHR95% CI value

MPA (vs. IgA-N)15.81.91–1310.00090.350.01–37.90.65774
Age (15 years increase)2.011.13–3.600.0129
Male (vs. Female)0.640.15–2.670.5302
MAP (10 mm Hg increase)2.061.08–3.930.0225
BMI (3 kg/m2 increase)1.100.61–1.990.7415
eGFR (30 mL/min/1.73 m2 decrease)13.01.88–90.5<0.00014.E+0.70.04942
T-chol (30 mg/dL increase)0.500.28–0.920.0170
TG (30 mg/dL increase)0.500.11–2.330.2424
U-Prot (0.5 g/g Cr increase)1.300.98–1.730.0907
U-RBC (25 counts/HPF increase)0.890.47–1.700.7247
ACEI/ARB use (vs. nonuse)0.880.19–4.130.8741
Antiplatelet drugs use (vs. nonuse)1.050.18–6.010.9526
Percentage of global glomerulosclerosisa74.36.89–803<0.000123.31.41–3860.00127
Percentage of crescentsb (cellular/fibrocellular/fibrous)1.960.98–3.890.0564
Tubular atrophy and interstitial fibrosisc10.02.42–41.70.00012.510.50–12.60.23657
Percentage of normal glomerulid0.080.02–0.38<0.00010.380.02–7.740.53297
Arteriosclerosis scoree1.890.90–4.100.0903
Arteriolosclerosis scoree2.601.13–6.570.0252

HR, hazard ratio; CI, confidence interval; MAP, mean arterial pressure; BMI, body mass index; Alb, serum albumin; eGFR, estimated glomerular filtration rate; T-chol, total cholesterol; TG, triglycerides; U-Prot, total urine protein; U-RBC, urine red blood cell count; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker. aGlobal glomerulosclerosis score: <10%, 0; 10 ≤ lesion < 25%, 1; 25 ≤ lesion < 50%, 2; 50 ≤ lesion < 75%, 3; ≥75%, 4. bCrescent score: <10%, 0; 10 ≤ lesion < 25%, 1; 25 ≤ lesion < 50%, 2; 50 ≤ lesion < 75%, 3; ≥75%, 4. cTubular atrophy and interstitial fibrosis score: <5%, 0; 5 ≤ lesion < 20, 1; 20 ≤ lesion < 50, 2; ≥50, 3. dNormal glomeruli score: >75%, 0; 50 < lesion ≤ 75, 1; 25 < lesion ≤ 50, 2; ≤ 25, 3. eArteriosclerosis and arteriolosclerosis score: none or low, 0; middle, 1; high, 2; and very high 3.